DIVERSIFIED HEALTHCARE TRUST financial data

Symbol
DHC, DHCNI, DHCNL on Nasdaq
Location
Newton, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 163% % 7.6%
Return On Equity -16% % 9.3%
Return On Assets -6.1% % 13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 242,121,025 shares 0.36%
Common Stock, Shares, Outstanding 242,121,025 shares 0.35%
Entity Public Float $776,900,000 USD 18%
Common Stock, Value, Issued $2,421,000 USD 0.33%
Weighted Average Number of Shares Outstanding, Basic 240,286,000 shares 0.31%
Weighted Average Number of Shares Outstanding, Diluted 240,286,000 shares 0.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,537,853,000 USD 2.8%
General and Administrative Expense $45,502,000 USD 72%
Costs and Expenses $1,742,823,000 USD 7.5%
Income Tax Expense (Benefit) $1,743,000 USD 273%
Net Income (Loss) Attributable to Parent $285,886,000 USD 23%
Earnings Per Share, Basic -1.19 USD/shares 23%
Earnings Per Share, Diluted -1.19 USD/shares 23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $105,407,000 USD -27%
Operating Lease, Right-of-Use Asset $16,537,000 USD -17%
Assets $4,361,250,000 USD -15%
Liabilities $2,695,682,000 USD -15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $12,000 USD 29%
Retained Earnings (Accumulated Deficit) $1,122,137,000 USD -20%
Stockholders' Equity Attributable to Parent $1,665,568,000 USD -15%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,665,568,000 USD -15%
Liabilities and Equity $4,361,250,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,243,000 USD -111%
Net Cash Provided by (Used in) Financing Activities $131,049,000 USD -1431%
Net Cash Provided by (Used in) Investing Activities $291,093,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 242,121,025 shares 0.35%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $156,801,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $121,799,000 USD -19%
Interest Paid, Excluding Capitalized Interest, Operating Activities $68,177,000 USD 114%
Deferred Tax Assets, Valuation Allowance $113,401,000 USD 8.3%
Deferred Tax Assets, Gross $113,401,000 USD 8.3%
Operating Lease, Liability $16,921,000 USD -17%
Depreciation $68,325,000 USD -2.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $285,881,000 USD 23%
Deferred Tax Assets, Operating Loss Carryforwards $110,013,000 USD 6.9%
Depreciation, Depletion and Amortization $261,923,000 USD -8.1%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $224,574,000 USD 17%